Validation of Five Seasons Sleep Tracking Mat for the Diagnosis of Obstructive Sleep Apnea
1 other identifier
observational
400
1 country
1
Brief Summary
This study will evaluate and compare the diagnostic accuracy and effectiveness of the Five Seasons Sleep Tracking Mat with the gold standard, polysomnography.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 9, 2025
CompletedFirst Posted
Study publicly available on registry
March 13, 2025
CompletedStudy Start
First participant enrolled
April 20, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2025
CompletedApril 16, 2025
April 1, 2025
5 months
March 9, 2025
April 15, 2025
Conditions
Outcome Measures
Primary Outcomes (2)
Diagnostic sensitivity (AHI = 5) of 5S Sleep Tracking Mat compared to PSG
The proportion of participants with Apnea Hypopnea Index (AHI) ≥ 5 events per hour according to 5S Sleep Tracking Mat in participants with AHI ≥ 5 events per hour according to PSG scored with American Academy of Sleep Medicine (AASM) v2.6 Guidelines. The point estimation of diagnostic sensitivity of 5S Sleep Tracking Mat will be compared to the threshold of 0.8, with the half width of 95% confidence interval being no more than 0.1.
Day 1
Diagnostic specificity (AHI = 5) of 5S Sleep Tracking Mat compared to PSG
The proportion of participants with Apnea Hypopnea Index (AHI) ≥ 5 events per hour according to 5S Sleep Tracking Mat in participants with AHI ≥ 5 events per hour according to PSG scored with American Academy of Sleep Medicine (AASM) v2.6 Guidelines. The point estimation of diagnostic specificity of 5S Sleep Tracking Mat will be compared to the threshold of 0.8, with the half width of 95% confidence interval being no more than 0.1.
Day 1
Secondary Outcomes (26)
Diagnostic sensitivity (AHI = 15) of 5S Sleep Tracking Mat compared to PSG
Day 1
Diagnostic specificity (AHI = 30) of 5S Sleep Tracking Mat compared to PSG
Day 1
Diagnostic sensitivity (AHI = 30) of 5S Sleep Tracking Mat compared to PSG
Day 1
Overall accuracy of 5S Sleep Tracking Mat at AHI = 5
Day 1
Overall accuracy of 5S Sleep Tracking Mat at AHI = 15
Day 1
- +21 more secondary outcomes
Interventions
The Five Seasons \[5S\] Sleep Tracking Mat consists of a main control box, monitoring mat, temperature/humidity sensor, power adapter, and light sensor. It utilizes Ballistocardiogram (BCG) technology to detect heartbeat, respiration, body movements, and snoring. The collected data is analyzed by a proprietary pre-trained AI model, enabling automatic detection of respiratory events, calculation of the Apnea-Hypopnea Index (AHI), and sleep stage interpretation. Compared to other sleep monitoring devices, it is non-contact and requires no wearable components, making it particularly suitable for long-term, daily home use.
Eligibility Criteria
Age between 18 and 70 years, with potential symptoms of snoring at night, daytime sleepiness, or self-reported poor sleep quality, suspected of having OSA, recruited by department of otorhinolaryncology in collaborative hospitals.
You may qualify if:
- Participants between 18 and 70 years, with potential symptoms of snoring at night, daytime sleepiness, or self-reported poor sleep quality, suspected of having OSA.
- Participants who are willing to undergo overnight PSG.
You may not qualify if:
- Participants with presence of severe cardiovascular or cerebrovascular diseases, or significant impairment of liver, kidney, or lung function.
- Participants with concurrent unstable respiratory diseases or other acute-phase respiratory illnesses.
- Participants using, at long term or currently, barbiturates, benzodiazepines, sedatives, or other medications that may affect sleep.
- Participants undergoing continuous positive airway pressure (CPAP) therapy or other sleep-related treatments on the study night.
- Participants coexisting insomnia, parasomnia, or other sleep disorders.
- Participants with psychiatric disorders.
- Participants refusing to sign the informed consent form.
- Participants unable to cooperate with the required examinations.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Shanghai 6th People's Hospitallead
- West China Hospitalcollaborator
- Second Affiliated Hospital of Soochow Universitycollaborator
- Dalian Municipal Central Hospitalcollaborator
- Third Hospital of Inner Mongolia Autonomous Regioncollaborator
- Beijing HuiLongGuan Hospitalcollaborator
Study Sites (1)
Shanghai Sixth People's Hospital
Shanghai, Shanghai Municipality, 200025, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr.
Study Record Dates
First Submitted
March 9, 2025
First Posted
March 13, 2025
Study Start
April 20, 2025
Primary Completion
September 30, 2025
Study Completion
September 30, 2025
Last Updated
April 16, 2025
Record last verified: 2025-04
Data Sharing
- IPD Sharing
- Will share
All IPD that underlie results in a publication will be shared.